Cargando…

A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis

The effects of an analgesic treatment (lidocaine patches) on brain activity in chronic low back pain (CBP) and in knee osteoarthritis (OA) were investigated using serial fMRI (contrasting fMRI between before and after two weeks of treatment). Prior to treatment brain activity was distinct between th...

Descripción completa

Detalles Bibliográficos
Autores principales: Baliki, Marwan N, Geha, Paul Y, Jabakhanji, Rami, Harden, Norm, Schnitzer, Thomas J, Apkarian, A Vania
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584040/
https://www.ncbi.nlm.nih.gov/pubmed/18950528
http://dx.doi.org/10.1186/1744-8069-4-47
_version_ 1782160766953062400
author Baliki, Marwan N
Geha, Paul Y
Jabakhanji, Rami
Harden, Norm
Schnitzer, Thomas J
Apkarian, A Vania
author_facet Baliki, Marwan N
Geha, Paul Y
Jabakhanji, Rami
Harden, Norm
Schnitzer, Thomas J
Apkarian, A Vania
author_sort Baliki, Marwan N
collection PubMed
description The effects of an analgesic treatment (lidocaine patches) on brain activity in chronic low back pain (CBP) and in knee osteoarthritis (OA) were investigated using serial fMRI (contrasting fMRI between before and after two weeks of treatment). Prior to treatment brain activity was distinct between the two groups: CBP spontaneous pain was associated mainly with activity in medial prefrontal cortex, while OA painful mechanical knee stimulation was associated with bilateral activity in the thalamus, secondary somatosensory, insular, and cingulate cortices, and unilateral activity in the putamen and amygdala. After 5% lidocaine patches were applied to the painful body part for two weeks, CBP patients exhibited a significant decrease in clinical pain measures, while in OA clinical questionnaire based outcomes showed no treatment effect but stimulus evoked pain showed a borderline decrease. The lidocaine treatment resulted in significantly decreased brain activity in both patient groups with distinct brain regions responding in each group, and sub-regions within these areas were correlated with pain ratings specifically for each group (medial prefrontal cortex in CBP and thalamus in OA). We conclude that the two chronic pain conditions involve distinct brain regions, with OA pain engaging many brain regions commonly observed in acute pain. Moreover, lidocaine patch treatment modulates distinct brain circuitry in each condition, yet in OA we observe divergent results with fMRI and with questionnaire based instruments.
format Text
id pubmed-2584040
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25840402008-11-18 A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis Baliki, Marwan N Geha, Paul Y Jabakhanji, Rami Harden, Norm Schnitzer, Thomas J Apkarian, A Vania Mol Pain Research The effects of an analgesic treatment (lidocaine patches) on brain activity in chronic low back pain (CBP) and in knee osteoarthritis (OA) were investigated using serial fMRI (contrasting fMRI between before and after two weeks of treatment). Prior to treatment brain activity was distinct between the two groups: CBP spontaneous pain was associated mainly with activity in medial prefrontal cortex, while OA painful mechanical knee stimulation was associated with bilateral activity in the thalamus, secondary somatosensory, insular, and cingulate cortices, and unilateral activity in the putamen and amygdala. After 5% lidocaine patches were applied to the painful body part for two weeks, CBP patients exhibited a significant decrease in clinical pain measures, while in OA clinical questionnaire based outcomes showed no treatment effect but stimulus evoked pain showed a borderline decrease. The lidocaine treatment resulted in significantly decreased brain activity in both patient groups with distinct brain regions responding in each group, and sub-regions within these areas were correlated with pain ratings specifically for each group (medial prefrontal cortex in CBP and thalamus in OA). We conclude that the two chronic pain conditions involve distinct brain regions, with OA pain engaging many brain regions commonly observed in acute pain. Moreover, lidocaine patch treatment modulates distinct brain circuitry in each condition, yet in OA we observe divergent results with fMRI and with questionnaire based instruments. BioMed Central 2008-10-25 /pmc/articles/PMC2584040/ /pubmed/18950528 http://dx.doi.org/10.1186/1744-8069-4-47 Text en Copyright © 2008 Baliki et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Baliki, Marwan N
Geha, Paul Y
Jabakhanji, Rami
Harden, Norm
Schnitzer, Thomas J
Apkarian, A Vania
A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis
title A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis
title_full A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis
title_fullStr A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis
title_full_unstemmed A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis
title_short A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis
title_sort preliminary fmri study of analgesic treatment in chronic back pain and knee osteoarthritis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584040/
https://www.ncbi.nlm.nih.gov/pubmed/18950528
http://dx.doi.org/10.1186/1744-8069-4-47
work_keys_str_mv AT balikimarwann apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT gehapauly apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT jabakhanjirami apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT hardennorm apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT schnitzerthomasj apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT apkarianavania apreliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT balikimarwann preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT gehapauly preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT jabakhanjirami preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT hardennorm preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT schnitzerthomasj preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis
AT apkarianavania preliminaryfmristudyofanalgesictreatmentinchronicbackpainandkneeosteoarthritis